-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
LIPELLA PHARMACEUTICALS INC. quarterly and annual Net Income (Loss) Attributable to Parent history and change rate from 2021 to Q3 2025.
- LIPELLA PHARMACEUTICALS INC. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $-1,254,078, a 13.2% increase year-over-year.
- LIPELLA PHARMACEUTICALS INC. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $-5,329,759, a 25% decline year-over-year.
- LIPELLA PHARMACEUTICALS INC. annual Net Income (Loss) Attributable to Parent for 2024 was $-5,016,264, a 8.6% decline from 2023.
- LIPELLA PHARMACEUTICALS INC. annual Net Income (Loss) Attributable to Parent for 2023 was $-4,618,965, a 77.8% decline from 2022.
- LIPELLA PHARMACEUTICALS INC. annual Net Income (Loss) Attributable to Parent for 2022 was $-2,597,692, a 39.3% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)